Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 360mg equivalent to 250 mg erythromycin base;   - tablet - 250 mg - active: erythromycin estolate 360mg equivalent to 250 mg erythromycin base  

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 720mg equivalent to 500 mg erythromycin base;  ;   - tablet - 500 mg - active: erythromycin estolate 720mg equivalent to 500 mg erythromycin base     excipient: erythrosine   glycerol hyprolose hypromellose magnesium stearate methanol methylated spirits methylene chloride purified water quinoline yellow starch sunset yellow fcf titanium dioxide trichloroethane white beeswax

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - glucagon hydrochloride 1mg equivalent to 1 unit, (bovine, north america) - solution for injection - 1 mg - active: glucagon hydrochloride 1mg equivalent to 1 unit, (bovine, north america) excipient: lactose monohydrate glycerol phenol water for injection

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - somatropin 4 [iu] equivalent to 1.48 mg somatropin;   - solution for injection - 4 iu - active: somatropin 4 [iu] equivalent to 1.48 mg somatropin   excipient: glycerol metacresol water for injection

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - somatropin 7.29mg equivalent to 19.69 iu somatropin - solution for injection - 18 iu - active: somatropin 7.29mg equivalent to 19.69 iu somatropin excipient: dibasic sodium phosphate glycine mannitol phosphoric acid sodium hydroxide glycerol hydrochloric acid metacresol sodium hydroxide water for injection

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - somatropin 14.57mg equivalent to 39.38 iu somatropin - solution for injection - 36 iu - active: somatropin 14.57mg equivalent to 39.38 iu somatropin excipient: dibasic sodium phosphate glycine mannitol phosphoric acid sodium hydroxide glycerol hydrochloric acid metacresol sodium hydroxide water for injection

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - somatropin 29.14mg equivalent to 78.75 iu somatropin - solution for injection - 72 iu - active: somatropin 29.14mg equivalent to 78.75 iu somatropin excipient: dibasic sodium phosphate glycine mannitol phosphoric acid sodium hydroxide glycerol hydrochloric acid metacresol sodium hydroxide water for injection

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 80% isophane and 20% regular insulin) - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 80% isophane and 20% regular insulin) excipient: dibasic sodium phosphate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 iu/ml - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 iu/ml excipient: hydrochloric acid as 10% solution for ph adjustment methyl hydroxybenzoate sodium acetate trihydrate sodium chloride sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin zinc suspension, crystalline, human, prb 100 [iu] - solution for injection - 100 iu/ml - active: insulin zinc suspension, crystalline, human, prb 100 [iu] excipient: methyl hydroxybenzoate sodium acetate sodium chloride water for injection zinc oxide